Interstitial lung disease is significant risk factor for lung inflammation
Pretreatment interstitial lung disease is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy alone, researchers say.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Interstitial Lung Disease | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Science